Business Description

Bio-Rad Laboratories Inc. is a leading provider of life science research and clinical diagnostic products, founded in 1952 and headquartered in Hercules, California, United States. The company generates revenue through advanced laboratory instruments, reagents, and software sold to research institutions, hospitals, and biopharma companies. Under the leadership of CEO Norman H. Schwartz, Bio-Rad continues to drive innovation with flagship products including the GelDoc and Bio-Plex systems. With strategic investments in digital automation and next-generation diagnostics, the firm is well-positioned for sustained global growth.

Everything on Bio-Rad Laboratories Inc.

Revenue (FY2025) $2.58B
YoY growth +0.7%
Operating margin 1.8%
Direction Expanding
Gross margin 51.9%
Net margin 29.4%

Earnings Transcripts

View all transcripts ↗

Share Repurchase Program

Total authorized
$1.0 billion (2023 Share Repurchase Program: $500 million authorized in July 2023, plus an additional $500 million authorized in July 2024)
Remaining (FY2025)
$284.6 million (as of December 31, 2025)
Latest FY repurchased
$295.5 million (payments for purchases of treasury stock, year ended December 31, 2025)

Named Competitors

Becton DickinsonDanaherMerck KGaAQiagen N.V.Thermo Fisher ScientificAbbott LaboratoriesbioMerieuxDiaSorinWerfenQuidelOrthoRocheSiemens Healthineers +1 more

Recent SEC Filings

2026-04-30 Reported quarterly results (+1 more) View filing ↗
2026-04-24 Leadership change (directors/officers) (+1 more) View filing ↗
2026-02-19 Regulation FD disclosure View filing ↗
2026-02-12 Reported quarterly results (+1 more) View filing ↗
2025-10-29 Reported quarterly results (+1 more) View filing ↗
2025-09-30 Regulation FD disclosure View filing ↗
2025-08-26 Regulation FD disclosure View filing ↗
2025-07-31 Reported quarterly results (+1 more) View filing ↗
2025-07-28 Leadership change (directors/officers) (+1 more) View filing ↗
2025-06-30 Other event View filing ↗
2025-05-01 Reported quarterly results View filing ↗
2025-04-25 Shareholder vote results View filing ↗

More Companies

See how VectorShift works for your firm

Request Demo